CivaTech Oncology
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
104 Dr Taiwan, Durham, North Carolina, 2...Phone Number
(919) 314-5515Website
www.civatechoncology.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About CivaTech Oncology
CivaTech Oncology is a North Carolina-based corporation specializing in innovative polymer-based low dose rate brachytherapy devices for cancer treatment. Their products, including CivaSheet, CivaString, and CivaDerm, are designed to enhance localized radiation therapy by minimizing trauma and improving treatment outcomes. The company targets radiation oncologists and cancer patients, offering customizable solutions that integrate seamlessly into clinical workflows. CivaTech's FDA-cleared devices are aimed at treating various solid tumors, including prostate, pancreatic, and skin cancers.Explore more
CivaTech Oncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CivaTech Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once CivaTech Oncology has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when CivaTech Oncology launches new products
CivaTech Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on CivaTech Oncology recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if CivaTech Oncology is spiking on competitors!
Check if CivaTech Oncology has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at CivaTech Oncology
Click to see if CivaTech Oncology had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at CivaTech Oncology
Find more new buyers
Compare Similar Companies to CivaTech Oncology
Compare insights from companies similar to CivaTech Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CivaTech Oncology is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CivaTech Oncology is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CivaTech Oncology.
CivaTech Oncology financials insights
Gather financial insights about CivaTech Oncology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Private Equity
$700K
2014
Private Equity
$1.5M
2015
Debt
$2.7M
2017
Private Equity
$916K
2020
Debt
$150K
CivaTech Oncology Tech Stack
A closer look at the technologies used by CivaTech Oncology
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Funding
Project
Spending/Investment
Event
will be attending the 2022 BIO International Convention conference as an exhibitor. The event will occur from June 13 to June 16, 2022.
Event
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding CivaTech Oncology
Sign Up For FreeTo access detailed company insights
CivaTech Oncology is a North Carolina-based corporation specializing in innovative polymer-based low dose rate brachytherapy devices for cancer treatment. Their products, including CivaSheet, CivaString, and CivaDerm, are designed to enhance localized radiation therapy by minimizing trauma and improving treatment outcomes. The company targets radia... Read More
